Merlo A - Search Results

1

Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ.

Schulte A, Liffers K, Kathagen A, Riethdorf S, Zapf S, Merlo A, Kolbe K, Westphal M, Lamszus K. Schulte A, et al. Among authors: merlo a. Neuro Oncol. 2013 Oct;15(10):1289-301. doi: 10.1093/neuonc/not093. Epub 2013 Jul 21. Neuro Oncol. 2013. PMID: 23877316 Free PMC article.

2

PI3Kinase signaling in glioblastoma.

Lino MM, Merlo A. Lino MM, et al. Among authors: merlo a. J Neurooncol. 2011 Jul;103(3):417-27. doi: 10.1007/s11060-010-0442-z. Epub 2010 Nov 10. J Neurooncol. 2011. PMID: 21063898 Free PMC article. Review.

3

Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial.

Hegi ME, Diserens AC, Bady P, Kamoshima Y, Kouwenhoven MC, Delorenzi M, Lambiv WL, Hamou MF, Matter MS, Koch A, Heppner FL, Yonekawa Y, Merlo A, Frei K, Mariani L, Hofer S. Hegi ME, et al. Among authors: merlo a. Mol Cancer Ther. 2011 Jun;10(6):1102-12. doi: 10.1158/1535-7163.MCT-11-0048. Epub 2011 Apr 6. Mol Cancer Ther. 2011. PMID: 21471286 Free article. Clinical Trial.

4

SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.

Moncayo G, Grzmil M, Smirnova T, Zmarz P, Huber RM, Hynx D, Kohler H, Wang Y, Hotz HR, Hynes NE, Keller G, Frank S, Merlo A, Hemmings BA. Moncayo G, et al. Among authors: merlo a. Neuro Oncol. 2018 Apr 9;20(5):621-631. doi: 10.1093/neuonc/noy008. Neuro Oncol. 2018. PMID: 29401256 Free PMC article.

5

EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms.

Del Vecchio CA, Giacomini CP, Vogel H, Jensen KC, Florio T, Merlo A, Pollack JR, Wong AJ. Del Vecchio CA, et al. Among authors: merlo a. Oncogene. 2013 May 23;32(21):2670-81. doi: 10.1038/onc.2012.280. Epub 2012 Jul 16. Oncogene. 2013. PMID: 22797070

6

Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA-substance P--results from a phase I study.

Cordier D, Forrer F, Kneifel S, Sailer M, Mariani L, Mäcke H, Müller-Brand J, Merlo A. Cordier D, et al. Among authors: merlo a. J Neurooncol. 2010 Oct;100(1):129-36. doi: 10.1007/s11060-010-0153-5. Epub 2010 Mar 10. J Neurooncol. 2010. PMID: 20217458 Clinical Trial.

7

Pten signaling in gliomas.

Knobbe CB, Merlo A, Reifenberger G. Knobbe CB, et al. Among authors: merlo a. Neuro Oncol. 2002 Jul;4(3):196-211. Neuro Oncol. 2002. PMID: 12084351 Free PMC article. Review.

8

Translating biology into clinic: the case of glioblastoma.

Lino M, Merlo A. Lino M, et al. Among authors: merlo a. Curr Opin Cell Biol. 2009 Apr;21(2):311-6. doi: 10.1016/j.ceb.2008.12.009. Epub 2009 Feb 14. Curr Opin Cell Biol. 2009. PMID: 19217766 Review.

9

Combination of sublethal concentrations of epidermal growth factor receptor inhibitor and microtubule stabilizer induces apoptosis of glioblastoma cells.

Failly M, Korur S, Egler V, Boulay JL, Lino MM, Imber R, Merlo A. Failly M, et al. Among authors: merlo a. Mol Cancer Ther. 2007 Feb;6(2):773-81. doi: 10.1158/1535-7163.MCT-06-0566. Mol Cancer Ther. 2007. PMID: 17308073

10

Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells.

Jones G, Machado J Jr, Merlo A. Jones G, et al. Among authors: merlo a. Cancer Res. 2001 Jul 1;61(13):4978-81. Cancer Res. 2001. PMID: 11431328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

418 results

Search Page